Heakyung Kim, MD
Board Certifications:
Physical Medicine and Rehabilitation, Pediatric Rehabilitation Medicine
Accepting New Patients
Treats Children
Overview
Areas of Expertise / Conditions Treated
Abnormal Gait, Baclofen Pump Implantation, Cerebral Palsy, Foot Deformity, Inflammatory Muscle Disease, Injection, Botulinum Toxin, Muscle Atrophy, Muscle Pain, Muscle Stiffness, Musculoskeletal Rehabilitation, Neuromuscular Disorder, Pediatric Cerebral Palsy, Pediatric Neuromuscular Disease, Pediatric Pain Management, Pediatric Stroke, Spasticity, Spina Bifida, Spinal Cord Injury, Sports Injury, Traumatic Brain Injury
Academic Appointments
- A. David Gurewitsch Professor of Rehabilitation and Regenerative Medicine and Professor of Pediatrics at the Columbia University Medical Center
- Professor of Rehabilitation and Regenerative Medicine at Weill Cornell Medical College
- Professor of Pediatrics at Weill Cornell Medical College
Administrative Titles
- Director, Pediatric Physical Medicine and Rehabilitation
- Vice Chair for Pediatric Physical Medicine & Rehabilitation, Dept. of Rehabilitation & Regenerative Medicine
- Fellowship Program Director of Pediatric Rehabilitation Medicine, Columbia University P&S/NYPH
Hospital Affiliations
- NewYork-Presbyterian Komansky Children's Hospital
- NewYork-Presbyterian / Columbia University Irving Medical Center
- NewYork-Presbyterian Morgan Stanley Children's Hospital
Languages
- Korean
Gender
- Female
Schedule an Appointment
Phone Appointments
New and Existing Patients:
Insurance Accepted
Aetna
- EPO
- HMO
- Medicare Managed Care
- NYP Employee Plan
- NY Signature
- POS
- PPO
- Signature Administrators
- Student Health
Affinity
- Essential Plan
- Medicaid Managed Care
AgeWell
- Medicare Managed Care
- Special Needs Plan
Amida Care
- Special Needs Plan
Capital District Physician Health Plan
- Capital District Physician Health Plan
Cigna
- EPO
- Great West
- HMO
- POS
- PPO
Emblem/GHI
- Medicare Managed Care
- PPO
Emblem/HIP
- ConnectiCare
- EPO
- Essential Plan
- HMO
- Medicaid Managed Care
- Medicare Managed Care
- POS
- PPO
- Select Care (Exchange)
- Vytra
Empire Blue Cross Blue Shield
- EPO
- Medicare Managed Care
- PPO
Empire Blue Cross Blue Shield HealthPlus
- Child/Family Health Plus
- Essential Plan
- Medicaid Managed Care
Fidelis Care
- Child/Family Health Plus
- Medicaid Managed Care
- Medicare Managed Care
Healthfirst
- Child/Family Health Plus
- Leaf (Exchange)
- Medicaid Managed Care
- Medicare Managed Care
Local 1199
- Local 1199
MagnaCare
- MagnaCare
Multiplan
- Multiplan
MVP Health Care
- Child/Family Health Plus
- Essential Plan
- HMO
- Medicaid Managed Care
Oxford Health Plans
- Freedom
- Liberty
UnitedHealthcare
- Columbia University Employee Plan
- Compass (Exchange)
- HMO
- Medicaid (Community Plan)
- Medicare Managed Care
- POS
- PPO
VNSNY CHOICE
- Medicare Managed Care
- SelectHealth
- Special Needs Plan
WellCare
- Medicaid Managed Care
- Medicare Managed Care
*Please contact the provider’s office directly to verify that your particular insurance is accepted.
Credentials & Experience
Education & Training
- Ewha Women's University College of Medicine (Republic of Korea)
- Residency: Kessler Institute for Rehabilitation Medicine -UMDNJ
- Fellowship: Kessler Institute for Rehabilitation Medicine -UMDNJ
Board Certifications
- Physical Medicine and Rehabilitation
- Pediatric Rehabilitation Medicine
Honors & Awards
New York Super Doctors 2018, 2017, 2016, 2015, 2012
New York Magazine: Top Doctors 2018, 2017, 2016, 2015, 2014, 2013, 2012
Top Doctors New York Metro Area: 2019, 2018, 2017, 2016
America's Top Doctor
NY Top Doctor
Research
Grants
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF TEV-50717 (DEUTETRABENAZINE) FOR THE TREATMENT OF DYSKINESIA IN CEREBRAL PALSY IN CHILDREN AND ADOLESCENTS (P&S Industry Clinical Trial)
Oct 22 2019 - Oct 22 2024
EFFECT OF SINGLE EVENT MULTI LEVEL CHEMONEUROLYSIS WITH ABOBOTULINUMTOXINA ON ENERGY EXPENDITURE AND WALKING EFFICIENCY (P&S Industry Clinical Trial)
Feb 11 2018 - Feb 11 2023
BOTOX TREATMENT IN PEDIATRIC UPPER LIMB SPASTICITY: OPEN-LABEL STUDY (P&S Industry Clinical Trial)
Jan 15 2013 - Jan 15 2018